Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Endocrinol Rev ; 2 Suppl 2: 267-71, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16462709

RESUMO

OBJECTIVE: To study the evolution of glucose disturbances (GD) in patients with thalassemia aged 11-30 years. DESIGN AND METHODS: A total of 263 patients, classified into three groups on the basis of age, and period of follow-up ranging from 2-10 years, were studied. Evolution of GD was assessed through serial oral glucose tolerance tests (OGTT), based on WHO criteria. RESULTS: At baseline (11-14 years of age) evaluation of OGTT disclosed a prevalence of 16.3% of impaired glucose tolerance (IGT), and zero for diabetic tolerance (DT). Prevalence of IGT increased progressively up to 39% in the following 4 years, but remained constant during the last 6 years of observation. In contrast, DT had a very low prevalence, beginning with 0.5% at 13-16 years, increasing to 2.4% by the age of 21-24 years. CONCLUSIONS: During puberty and early adolescence impaired glucose tolerance (IGT) was found in a considerable proportion of thalassemics. In contrast, DT was infrequent and progression to DM was slow. Only 12.4% of patients with IGT developed DT within a period of 10 years. Further studies are necessary to identify all of the factors contributing to abnormalities of glucose metabolism in thalassemic patients.


Assuntos
Diabetes Mellitus/etiologia , Intolerância à Glucose/complicações , Talassemia beta/complicações , Adolescente , Adulto , Fatores Etários , Transfusão de Sangue , Terapia por Quelação , Criança , Diabetes Mellitus/metabolismo , Intolerância à Glucose/metabolismo , Teste de Tolerância a Glucose , Humanos , Estudos Longitudinais , Estudos Prospectivos , Talassemia beta/metabolismo , Talassemia beta/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...